HealthPhoto: Hindu HealthExperts Criticize India's Cancer Drug Price Caps as Insufficient
India's government has capped trade margins on 137 non-scheduled anti-cancer drugs to reduce treatment costs. However, experts say this short-term measure is tokenistic and will not significantly benefit patients unless structural reforms occur. They emphasize the need to address manufacturing pricing and implement large-scale government procurement to stabilize drug prices and truly lower cancer treatment expenses.
Hindu Health·

